Alpha-glucosidase inhibitor decreases the risk of colorectal adenoma in the aged with Type 2 diabetes.Published in:Scientific Reports, 2025, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-84294-3By:Xia, Dingchao;Jin, Lanling;Wang, Binfeng;Jin, Yi;Zheng, Qun;Xu, Jie;Chen, SenzhongPublication type:Article